🔗 Visit the ClinicalTrials.gov page for NCT02007070
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Immunotherapy in the treatment of non-small cell lung cancer. | Lung Cancer | 2014 | 1.35 |
| 2 | Assays for predicting and monitoring responses to lung cancer immunotherapy. | Cancer Biol Med | 2015 | 1.23 |
| 3 | Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. | Oncoimmunology | 2015 | 1.06 |
| 4 | Cancer immunotherapy in clinical practice -- the past, present, and future. | Chin J Cancer | 2014 | 0.98 |
| 5 | Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy. | Med Oncol | 2014 | 0.80 |
| 6 | Promising targets and current clinical trials in metastatic squamous cell lung cancer. | Front Oncol | 2014 | 0.78 |
| 7 | PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. | Onco Targets Ther | 2016 | 0.78 |
| 8 | Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date. | Onco Targets Ther | 2016 | 0.75 |